According to a recent Senate report (pdf), drug shortages increased to nearly 30 percent between 2021 and 2022. “Drug shortages are increasing, lasting longer,” the Senate report said. “The number of active drug shortages in the U.S. reached a peak of 295 at the end of 2022.” Though drug shortages are not uncommon, the current shortage…
‘Hard Reality’ Getting Pharma Companies to Lower Drug Prices: Federal Memo
Health Minister Jean-Yves Duclos was told of the “hard reality” of getting pharmaceutical companies to lower their drug prices before he urged an independent federal agency to pause the discussion in favour of more consultation, a 2021 memo shows. “After five years, myriad policy proposals and many hundreds of hours of consultation, it would appear…
Pharma Companies ‘Not Amenable’ to Lowering Drug Prices: Federal Memo
Health Minister Jean-Yves Duclos was told of the “hard reality” of getting pharmaceutical companies to lower their drug prices before he urged an independent federal agency to pause the discussion in favour of more consultation, a 2021 memo shows. “After five years, myriad policy proposals and many hundreds of hours of consultation, it would appear…
After Two Years of Legislative Stalls, Largest Pharmacy Benefit Managers Facing Questions on Nation’s Drug Prices
It’s a question echoed throughout every corner of the United States: Why are prescription drug prices so high? A Congressional committee is aiming to find out. Rep. James Comer (R-Ky.) announced a formal investigation on March 1 after more than two years of legislative attempts to demand transparency and accountability from the nation’s largest pharmacy…
The Untold Story of a ‘Miracle Drug’
For 35 years, ivermectin was hailed as a miracle drug. It had an incredible impact on millions of people’s lives around the world who suffered from diseases like river blindness, scabies, and elephantiasis, without side effects and at an affordable price. The scientists who discovered it even won a Nobel prize. Some doctors tried to…
How We Have Been Misled About Antidepressants
Commentary Our umbrella review that revealed no links between serotonin and depression has caused shock waves among the general public, but has been dismissed as old news by psychiatric opinion leaders. This disjunction begs the questions of why the public has been fed this narrative for so long, and what antidepressants are actually doing if they are not reversing…
Frequent Interactions Between Clinicans and Big Pharma a Conflict of Interest: Expert
An expert in pharmaceutical policy has said that the frequent interactions between pharmaceutical companies and health professionals can pose a conflict of interest for clinicians. Prof. Barbara Mintzes told The Epoch Times that research has demonstrated that there was a corollary between health professionals receiving a low price meal while being promoted a drug and…
Australian Clinicans Not Declaring Conflict of Interest For Pharma Funded Studies: Experts
Researchers from the University of Sydney have called for “more transparency” after their review has revealed that nearly half of 120 pharmaceutical trials had missing or omitted declarations of conflict of interest (COI). “Disclosures are crucial to keeping research transparent,” said co-author Assoc. Prof. Barbara Mintzes from the University of Sydney. Conflicts of interest in…
How China Fuels America’s Drug Problem
Commentary The vast majority of pharmaceuticals used in the United States come from China. That’s bad news for Americans, as both countries are now engaged in a new cold war. The U.S. Food and Drug Administration (FDA) approved 53 novel drugs in 2020, which averages out at about one new drug every seven days. The United…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`